BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20381362)

  • 1. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
    Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
    Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.
    Hamada Y; Abdel-Rahman H; Yamani A; Nguyen JT; Stochaj M; Hidaka K; Kimura T; Hayashi Y; Saito K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1649-53. PubMed ID: 18249539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Secretase inhibitors: modification at the P4 position and improvement of inhibitory activity in cultured cells.
    Hamada Y; Igawa N; Ikari H; Ziora Z; Nguyen JT; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ebina M; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4354-9. PubMed ID: 16757166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
    Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
    Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of interactions of BACE1-Arg235 with its ligands and design of BACE1 inhibitors with P2 pyridine scaffold.
    Hamada Y; Ohta H; Miyamoto N; Sarma D; Hamada T; Nakanishi T; Yamasaki M; Yamani A; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2009 May; 19(9):2435-9. PubMed ID: 19345096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel non-peptidic and small-sized BACE1 inhibitors.
    Hamada Y; Ohta H; Miyamoto N; Yamaguchi R; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1643-7. PubMed ID: 18261904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
    Hamada Y; Suzuki K; Nakanishi T; Sarma D; Ohta H; Yamaguchi R; Yamasaki M; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2014 Jan; 24(2):618-23. PubMed ID: 24360554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.
    Hamada Y; Nakanishi T; Suzuki K; Yamaguchi R; Hamada T; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4640-4. PubMed ID: 22726930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent BACE-1 inhibitors containing a new hydroxyethylene (HE) scaffold: exploration of P1' alkoxy residues and an aminoethylene (AE) central core.
    Björklund C; Adolfsson H; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2010 Feb; 18(4):1711-23. PubMed ID: 20122837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
    Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
    Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1.
    Kortum SW; Benson TE; Bienkowski MJ; Emmons TL; Prince DB; Paddock DJ; Tomasselli AG; Moon JB; LaBorde A; TenBrink RE
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3378-83. PubMed ID: 17434734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiophene substituted acylguanidines as BACE1 inhibitors.
    Fobare WF; Solvibile WR; Robichaud AJ; Malamas MS; Manas E; Turner J; Hu Y; Wagner E; Chopra R; Cowling R; Jin G; Bard J
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5353-6. PubMed ID: 17761418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.
    Sealy JM; Truong AP; Tso L; Probst GD; Aquino J; Hom RK; Jagodzinska BM; Dressen D; Wone DW; Brogley L; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Dappen MS; Toth G; Pan H; Ruslim L; Miller J; Bova MP; Sinha S; Quinn KP; Sauer JM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6386-91. PubMed ID: 19811916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.